CH0499880968
CH0499880968
ADC Therapeutics SA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 81.357.000 | 70.837.000 | 14.9% |
| Cost of Revenue | 5.798.000 | 5.949.000 | 2.5% |
| Gross Profit | 75.559.000 | 64.888.000 | 16.4% |
| 182.766.000 | 194.479.000 | 6.0% | |
| Operating Income | -107.207.000 | -129.591.000 | 17.3% |
| Pretax Income | -141.608.000 | -156.136.000 | 9.3% |
| Net Income Common Stockholders | -142.623.000 | -157.846.000 | 9.6% |
| -- | -- | -- | |
| -- | -- | -- |